Global Repurposed Drugs Market Growth (Status and Outlook) 2024-2030

2024

Global Repurposed Drugs Market Growth (Status and Outlook) 2024-2030

Name: Global Repurposed Drugs Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001226
Price: 3450 USD
Availability: InStock
Rating: 4 (9.5 reviews)

The global Medical-Grade Textiles market is projected to grow from US$ 14,930 million in 2024 to US$ 19,160 million in 2030, fueled by increasing demand for textiles used in medica

Bonafide Trust
24-09-2024
Pages : 117
Figures : 81
Tables : 110
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global repurposed drugs market is a rapidly growing sector that focuses on the repositioning of existing drugs for new therapeutic indications. This approach involves taking previously approved drugs and exploring their potential to treat conditions other than their original purpose. The repurposed drugs market has gained significant attention due to its potential to reduce the time, cost, and risk associated with developing new medications from scratch. By utilizing drugs that have already undergone clinical trials and regulatory approval, pharmaceutical companies can bypass some of the most expensive and time-consuming phases of drug development. The market's growth is driven by the increasing need for treatments for various unmet medical conditions, the rising prevalence of chronic diseases, and the growing focus on finding alternative therapies, especially in the context of urgent global health challenges. The COVID-19 pandemic highlighted the importance of repurposed drugs, as existing medications were quickly assessed for their potential in combating the virus. Additionally, the rising incidence of antimicrobial resistance and the need for new antibiotics have further fueled the interest in repurposing existing drugs for infectious diseases. As a result, the market is expected to continue its expansion, with pharmaceutical companies, healthcare providers, and research institutions focusing on identifying new therapeutic uses for already-approved drugs. The use of technologies like artificial intelligence, machine learning, and big data analytics has further accelerated the discovery of potential repurposed drugs, driving innovation and efficiency in the market.

According to Publisher, the global Medical-Grade Textiles market size is projected to grow from US$ 14930 million in 2024 to US$ 19160 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030. The repurposed drugs market is growing across several regions, with North America and Europe leading the charge due to their well-established pharmaceutical industries and robust healthcare systems. North America, particularly the United States, benefits from substantial investment in research and development, a large number of pharmaceutical companies, and an innovation-driven healthcare environment. The market in North America is also supported by favorable regulatory frameworks, such as the U.S. Food and Drug Administration’s (FDA) fast track and orphan drug designations, which encourage the repurposing of drugs for rare diseases and conditions. Europe follows closely behind, with countries like Germany, the UK, and France driving the growth of the market due to their advanced healthcare systems and strong pharmaceutical research base. The European Medicines Agency (EMA) has also played a significant role in supporting drug repurposing efforts, further enhancing market opportunities. In the Asia Pacific region, emerging economies such as China, India, and Japan are witnessing rapid growth in the repurposed drugs market, driven by improving healthcare infrastructure, growing healthcare needs, and increasing investments in medical research. The prevalence of chronic diseases and the demand for cost-effective treatment solutions in these regions are also contributing to the market's expansion. Additionally, the rise of medical tourism in regions like India and Thailand is expected to boost the demand for repurposed drugs, as patients seek advanced treatments at more affordable prices. Latin America and the Middle East are also showing potential for growth, supported by improving healthcare access and increasing awareness about drug repurposing as an alternative treatment option. As healthcare systems worldwide continue to evolve, both developed and emerging markets are likely to play critical roles in the growth of the global repurposed drugs market.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global repurposed drugs market is segmented by type, with the major categories including small molecules, biologics, and vaccines. Small molecules are the largest segment of the repurposed drugs market, primarily due to their widespread use and ease of modification for new indications. These drugs are chemically synthesized and have low molecular weight, which allows them to be administered orally and absorbed effectively in the body. Small molecules are widely used in the treatment of various conditions, including cancer, cardiovascular diseases, and central nervous system disorders. Since small molecules are typically already approved for other conditions, repurposing them for new diseases offers significant advantages in terms of cost-effectiveness and speed of development. Many repurposed drugs in the oncology and infectious disease segments fall under the small molecule category, where they have been shown to exhibit efficacy in treating cancers and resistant infections. Biologics represent another important segment of the market, encompassing a variety of treatments such as monoclonal antibodies, gene therapies, and protein-based therapies. Biologics have the potential for more targeted treatments due to their ability to interact with specific molecules or cells in the body. Repurposing biologics for new conditions, such as autoimmune diseases, cancers, and rare genetic disorders, is becoming increasingly popular. These drugs tend to be more complex and expensive to produce than small molecules, but their high specificity and efficacy in certain therapeutic areas make them a valuable option for repurposing. Finally, vaccines form a growing segment of the market, particularly with the recent development of vaccines for new infectious diseases. Repurposing existing vaccine platforms has proven to be an effective strategy, as evidenced by the rapid development of COVID-19 vaccines based on existing technologies. The repurposed vaccines market is expected to grow further as vaccine platforms are adapted to target new strains of viruses or other infectious diseases.

In addition to type, the repurposed drugs market is segmented by application, which includes key therapeutic areas such as oncology, infectious diseases, central nervous system (CNS) disorders, cardiovascular diseases, and others. Oncology is one of the largest and most active therapeutic areas for repurposed drugs, with many existing medications being tested for their potential efficacy in treating various types of cancers. Repurposing drugs for cancer treatment offers significant benefits, as these drugs have already undergone safety and efficacy trials, reducing the time and cost required for approval. Several repurposed drugs have demonstrated promise in cancer treatment, including those originally developed for conditions like autoimmune diseases, metabolic disorders, and psychiatric conditions. Infectious diseases, including bacterial, viral, and fungal infections, also represent a major application area for repurposed drugs. The emergence of antimicrobial resistance and the growing threat of drug-resistant infections have accelerated the need for repurposed antibiotics and antiviral drugs. Existing drugs that were initially developed for other purposes are being explored for their effectiveness in treating resistant pathogens. Additionally, repurposed antivirals have been used to combat emerging infectious diseases, such as the novel coronavirus, showcasing the importance of this therapeutic area. Central nervous system disorders represent another promising application for repurposed drugs, with many existing medications being tested for their potential in treating neurological conditions such as Alzheimer's disease, Parkinson's disease, and depression. Drugs originally developed for mental health conditions are being investigated for their neuroprotective properties and ability to slow disease progression in neurodegenerative diseases. The cardiovascular disease segment is also seeing increased interest in repurposing existing drugs for conditions such as heart failure, hypertension, and arrhythmias. As the global prevalence of cardiovascular diseases rises, repurposing offers a cost-effective way to introduce new therapies into the market. Other application areas include rare diseases, metabolic disorders, and autoimmune conditions, all of which benefit from the ability to repurpose existing drugs to address unmet medical needs. The diversity of therapeutic areas under which drugs are being repurposed highlights the broad potential of this market and its ability to address a wide range of healthcare challenges.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Repurposed Drugs Market Size 2019-2030
2.1.2 Repurposed Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Repurposed Drugs Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Repurposed Drugs Market Size by Type
2.3.1 Repurposed Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
2.4 Repurposed Drugs Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Other
2.5 Repurposed Drugs Market Size by Application
2.5.1 Repurposed Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Repurposed Drugs Market Size Market Share by Application (2019-2024)
3 Repurposed Drugs Market Size by Player
3.1 Repurposed Drugs Market Size Market Share by Players
3.1.1 Global Repurposed Drugs Revenue by Players (2019-2024)
3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Repurposed Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Repurposed Drugs by Regions
4.1 Repurposed Drugs Market Size by Regions (2019-2024)
4.2 Americas Repurposed Drugs Market Size Growth (2019-2024)
4.3 APAC Repurposed Drugs Market Size Growth (2019-2024)
4.4 Europe Repurposed Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Repurposed Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Repurposed Drugs Market Size by Country (2019-2024)
5.2 Americas Repurposed Drugs Market Size by Type (2019-2024)
5.3 Americas Repurposed Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Repurposed Drugs Market Size by Region (2019-2024)
6.2 APAC Repurposed Drugs Market Size by Type (2019-2024)
6.3 APAC Repurposed Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Repurposed Drugs by Country (2019-2024)
7.2 Europe Repurposed Drugs Market Size by Type (2019-2024)
7.3 Europe Repurposed Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Repurposed Drugs by Region (2019-2024)
8.2 Middle East & Africa Repurposed Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Repurposed Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Repurposed Drugs Market Forecast
10.1 Global Repurposed Drugs Forecast by Regions (2025-2030)
10.1.1 Global Repurposed Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Repurposed Drugs Forecast
10.1.3 APAC Repurposed Drugs Forecast
10.1.4 Europe Repurposed Drugs Forecast
10.1.5 Middle East & Africa Repurposed Drugs Forecast
10.2 Americas Repurposed Drugs Forecast by Country (2025-2030)
10.2.1 United States Repurposed Drugs Market Forecast
10.2.2 Canada Repurposed Drugs Market Forecast
10.2.3 Mexico Repurposed Drugs Market Forecast
10.2.4 Brazil Repurposed Drugs Market Forecast
10.3 APAC Repurposed Drugs Forecast by Region (2025-2030)
10.3.1 China Repurposed Drugs Market Forecast
10.3.2 Japan Repurposed Drugs Market Forecast
10.3.3 Korea Repurposed Drugs Market Forecast
10.3.4 Southeast Asia Repurposed Drugs Market Forecast
10.3.5 India Repurposed Drugs Market Forecast
10.3.6 Australia Repurposed Drugs Market Forecast
10.4 Europe Repurposed Drugs Forecast by Country (2025-2030)
10.4.1 Germany Repurposed Drugs Market Forecast
10.4.2 France Repurposed Drugs Market Forecast
10.4.3 UK Repurposed Drugs Market Forecast
10.4.4 Italy Repurposed Drugs Market Forecast
10.4.5 Russia Repurposed Drugs Market Forecast
10.5 Middle East & Africa Repurposed Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Repurposed Drugs Market Forecast
10.5.2 South Africa Repurposed Drugs Market Forecast
10.5.3 Israel Repurposed Drugs Market Forecast
10.5.4 Turkey Repurposed Drugs Market Forecast
10.5.5 GCC Countries Repurposed Drugs Market Forecast
10.6 Global Repurposed Drugs Forecast by Type (2025-2030)
10.7 Global Repurposed Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Repurposed Drugs Product Offered
11.1.3 Teva Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Repurposed Drugs Product Offered
11.2.3 Novartis Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Repurposed Drugs Product Offered
11.3.3 Mylan Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Repurposed Drugs Product Offered
11.4.3 Johnson & Johnson Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Repurposed Drugs Product Offered
11.5.3 Pfizer Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Information
11.6.2 Bausch Health Repurposed Drugs Product Offered
11.6.3 Bausch Health Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bausch Health Main Business Overview
11.6.5 Bausch Health Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Repurposed Drugs Product Offered
11.7.3 GSK Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Information
11.8.2 ChemRar Group Repurposed Drugs Product Offered
11.8.3 ChemRar Group Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ChemRar Group Main Business Overview
11.8.5 ChemRar Group Latest Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Repurposed Drugs Product Offered
11.9.3 Glenmark Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Glenmark Main Business Overview
11.9.5 Glenmark Latest Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Information
11.10.2 Fujifilm Repurposed Drugs Product Offered
11.10.3 Fujifilm Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Main Business Overview
11.10.5 Fujifilm Latest Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Information
11.11.2 Dr. Reddy Repurposed Drugs Product Offered
11.11.3 Dr. Reddy Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Dr. Reddy Main Business Overview
11.11.5 Dr. Reddy Latest Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Information
11.12.2 R-Pharma Repurposed Drugs Product Offered
11.12.3 R-Pharma Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 R-Pharma Main Business Overview
11.12.5 R-Pharma Latest Developments
12 Research Findings and Conclusion

Table 1. Repurposed Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Repurposed Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 7. Repurposed Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 10. Global Repurposed Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Repurposed Drugs Revenue Market Share by Player (2019-2024)
Table 12. Repurposed Drugs Key Players Head office and Products Offered
Table 13. Repurposed Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Repurposed Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Repurposed Drugs Market Size Market Share by Regions (2019-2024)
Table 18. Global Repurposed Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Repurposed Drugs Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Repurposed Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Repurposed Drugs Market Size Market Share by Country (2019-2024)
Table 22. Americas Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 24. Americas Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 26. APAC Repurposed Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Repurposed Drugs Market Size Market Share by Region (2019-2024)
Table 28. APAC Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 30. APAC Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 32. Europe Repurposed Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Repurposed Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 36. Europe Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Repurposed Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Repurposed Drugs
Table 45. Key Market Challenges & Risks of Repurposed Drugs
Table 46. Key Industry Trends of Repurposed Drugs
Table 47. Global Repurposed Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Repurposed Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Repurposed Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Repurposed Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Teva Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 52. Teva Repurposed Drugs Product Offered
Table 53. Teva Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 57. Novartis Repurposed Drugs Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Mylan Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 62. Mylan Repurposed Drugs Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Mylan Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 67. Johnson & Johnson Repurposed Drugs Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Pfizer Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 72. Pfizer Repurposed Drugs Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Bausch Health Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 77. Bausch Health Repurposed Drugs Product Offered
Table 78. Bausch Health Main Business
Table 79. Bausch Health Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bausch Health Latest Developments
Table 81. GSK Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 82. GSK Repurposed Drugs Product Offered
Table 83. GSK Main Business
Table 84. GSK Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GSK Latest Developments
Table 86. ChemRar Group Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 87. ChemRar Group Repurposed Drugs Product Offered
Table 88. ChemRar Group Main Business
Table 89. ChemRar Group Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ChemRar Group Latest Developments
Table 91. Glenmark Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 92. Glenmark Repurposed Drugs Product Offered
Table 93. Glenmark Main Business
Table 94. Glenmark Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Latest Developments
Table 96. Fujifilm Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 97. Fujifilm Repurposed Drugs Product Offered
Table 98. Fujifilm Main Business
Table 99. Fujifilm Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Latest Developments
Table 101. Dr. Reddy Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 102. Dr. Reddy Repurposed Drugs Product Offered
Table 103. Dr. Reddy Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Dr. Reddy Main Business
Table 105. Dr. Reddy Latest Developments
Table 106. R-Pharma Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 107. R-Pharma Repurposed Drugs Product Offered
Table 108. R-Pharma Main Business
Table 109. R-Pharma Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. R-Pharma Latest Developments

Figure 1. Repurposed Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Repurposed Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Repurposed Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Repurposed Drugs Sales Market Share by Country/Region (2023)
Figure 8. Repurposed Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Repurposed Drugs Market Size Market Share by Type in 2023
Figure 10. Repurposed Drugs in Cardiovascular Diseases
Figure 11. Global Repurposed Drugs Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 12. Repurposed Drugs in Mental Illness
Figure 13. Global Repurposed Drugs Market: Mental Illness (2019-2024) & ($ Millions)
Figure 14. Repurposed Drugs in Cancer
Figure 15. Global Repurposed Drugs Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Repurposed Drugs in Other
Figure 17. Global Repurposed Drugs Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Repurposed Drugs Market Size Market Share by Application in 2023
Figure 19. Global Repurposed Drugs Revenue Market Share by Player in 2023
Figure 20. Global Repurposed Drugs Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 22. APAC Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Europe Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 25. Americas Repurposed Drugs Value Market Share by Country in 2023
Figure 26. United States Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Repurposed Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Repurposed Drugs Market Size Market Share by Type in 2023
Figure 32. APAC Repurposed Drugs Market Size Market Share by Application in 2023
Figure 33. China Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Repurposed Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Repurposed Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Repurposed Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 56. APAC Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 57. Europe Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 59. United States Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Canada Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 63. China Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Japan Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Korea Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 67. India Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Australia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Germany Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 70. France Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 71. UK Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Italy Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Russia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Spain Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Israel Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 80. Global Repurposed Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Repurposed Drugs Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted